Corda Investment Management’s Novartis NVS Stock Holding History

Corda Investment Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-77,038	Closed	-$7.45M	–	70
2024 Q1	$7.45M	Sell	77,038 -4,513	-6%	-$463K	0.59%	42
2023 Q4	$8.23M	Sell	81,551 -22,295	-21%	-$2.15M	0.69%	42
2023 Q3	$10.6M	Sell	103,846 -14,781	-12%	-$1.5M	0.96%	37
2023 Q2	$12M	Sell	118,627 -26,096	-18%	-$2.61M	0.94%	42
2023 Q1	$13.3M	Sell	144,723 -22,246	-13%	-$1.94M	1.06%	42
2022 Q4	$15.1M	Sell	166,969 -15,527	-9%	-$1.31M	1.23%	37
2022 Q3	$13.9M	Sell	182,496 -2,053	-1%	-$170K	1.24%	35
2022 Q2	$15.6M	Sell	184,549 -2,543	-1%	-$223K	1.32%	34
2022 Q1	$16.4M	Buy	187,092 +2,166	+1%	+$188K	1.27%	34
2021 Q4	$16.2M	Buy	184,926 +11,000	+6%	+$913K	1.27%	35
2021 Q3	$14.2M	Buy	173,926 +5,812	+3%	+$523K	1.24%	35
2021 Q2	$15.3M	Buy	168,114 +4,444	+3%	+$396K	1.32%	36
2021 Q1	$14M	Buy	163,670 +540	+0.3%	+$48.5K	1.27%	37
2020 Q4	$15.4M	Sell	163,130 -535	-0.3%	-$46.7K	1.55%	34
2020 Q3	$14.2M	Sell	163,665 -734	-0.4%	-$63.6K	1.55%	33
2020 Q2	$14.4M	Sell	164,399 -1,371	-0.8%	-$118K	1.65%	31
2020 Q1	$13.7M	Buy	165,770 +1,107	+0.7%	+$98.8K	1.71%	30
2019 Q4	$15.6M	Buy	164,663 +733	+0.4%	+$65.8K	1.67%	33
2019 Q3	$14.2M	Buy	163,930 +2,931	+2%	+$263K	1.56%	34
2019 Q2	$14.7M	Sell	160,999 -17,055	-10%	-$1.44M	1.59%	32
2019 Q1	$15.3M	Buy	178,054 +330	+0.2%	+$26.5K	1.77%	29
2018 Q4	$13.7M	Sell	177,724 -451	-0.3%	-$35.1K	1.68%	31
2018 Q3	$13.8M	Buy	178,175 +3,723	+2%	+$275K	1.63%	31
2018 Q2	$11.8M	Buy	174,452 +3,954	+2%	+$273K	1.46%	33
2018 Q1	$12.4M	Buy	170,498 +924	+0.5%	+$70.3K	1.54%	31
2017 Q4	$12.8M	Buy	169,574 +858	+0.5%	+$64.7K	1.53%	31
2017 Q3	$13M	Buy	168,716 +16,112	+11%	+$1.22M	1.68%	30
2017 Q2	$11.4M	Buy	152,604 +12,711	+9%	+$901K	1.62%	32
2017 Q1	$9.31M	Buy	139,893 +28,415	+25%	+$1.89M	1.39%	33
2016 Q4	$7.28M	Buy	111,478 +16,750	+18%	+$1.09M	1.13%	36
2016 Q3	$6.73M	Buy	94,728 +11,372	+14%	+$829K	1.1%	36
2016 Q2	$6.16M	Buy	83,356 +29,683	+55%	+$2.05M	0.99%	38
2016 Q1	$3.48M	Sell	53,673 -171	-0.3%	-$11.6K	0.61%	42
2015 Q4	$4.15M	Sell	53,844 -554	-1%	-$44K	0.78%	39
2015 Q3	$4.48M	Sell	54,398 -32,502	-37%	-$2.89M	0.87%	38
2015 Q2	$7.66M	Sell	86,900 -840	-1%	-$77.1K	1.43%	30
2015 Q1	$7.75M	Sell	87,740 -1,694	-2%	-$150K	1.43%	29
2014 Q4	$7.42M	Sell	89,434 -870	-1%	-$72.1K	1.4%	30
2014 Q3	$7.62M	Sell	90,304 -819	-0.9%	-$66.3K	1.58%	26
2014 Q2	$7.39M	Sell	91,123 -1,143	-1%	-$89.9K	1.54%	29
2014 Q1	$7.03M	Sell	92,266 -933	-1%	-$68K	1.73%	26
2013 Q4	$6.71M	Sell	93,199 -2,433	-3%	-$169K	1.61%	27
2013 Q3	$6.57M	Sell	95,632 -1,196	-1%	-$79.1K	1.79%	24
2013 Q2	$6.13M	Buy	+96,828	New	+$6.3M	2.08%	23

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CCM

Cullen Capital Management New York $9.75B AUM 21.81% 1-Year Est. Return

Corda Investment Management's NVS Position: Q2 2024 in Review

Corda Investment Management sold out of Novartis (NVS) in Q2 2024, closing a stake of 77,038 shares — an estimated $7.45M sold.

Corda Investment Management first reported a position in NVS in Q2 2013 and held it in 44 quarters. The position peaked at $16.4M in Q1 2022. 1,307 funds tracked by Wall St. Rank hold NVS as of Q2 2024.

Corda Investment Management reported no remaining Novartis position as of Q2 2024 after selling out during the quarter.
Corda Investment Management sold 77,038 Novartis shares in Q2 2024, an estimated $7.45M.
Corda Investment Management first reported a position in Novartis in Q2 2013 and held it in 44 quarters.
Corda Investment Management's Novartis position peaked at $16.4M in Q1 2022.
1,307 funds tracked by Wall St. Rank held Novartis as of Q2 2024.

Based on Corda Investment Management's 13F filing for Q2 2024, filed 30 Jul 2024.